Angela Hu
Overview
Explore the profile of Angela Hu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
290
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcia-Agundez A, Kay J, Li J, Gianfrancesco M, Rai B, Hu A, et al.
JAMIA Open
. 2024 Jun;
7(2):ooae051.
PMID: 38915730
Importance: Electronic health record textual sources such as medication signeturs (sigs) contain valuable information that is not always available in structured form. Commonly processed through manual annotation, this repetitive and...
2.
Yao P, Hu A, Mansour F, Nadeem I, Jiang Y, Athreya S
J Vasc Interv Radiol
. 2024 May;
35(9):1268-1277.
PMID: 38815751
Purpose: To analyze the effectiveness of image-guided energy ablation techniques with and without concurrent therapies in providing palliative pain relief in patients with bone metastases. Materials And Methods: Ovid Embase,...
3.
Bock F, Hu A, Cicale V, Larsen S, Lu X, Ostergaard J
Anal Chem
. 2023 Oct;
95(43):15861-15866.
PMID: 37857348
Transport within human tissue matrices, e.g., the subcutaneous tissue, exhibits some resemblance to chromatographic processes. Here, a porous matrix comprising agarose beads compatible with UV-vis imaging was developed for a...
4.
Santini V, Giagounidis A, Pelligra C, Franco-Villalobos C, Tang D, Morison J, et al.
Clin Lymphoma Myeloma Leuk
. 2022 Jun;
22(9):e874-e883.
PMID: 35710702
Background: For patients with lower-risk (LR) myelodysplastic syndromes (MDS), overall survival (OS) is rarely a primary clinical trial endpoint. Treatments such as lenalidomide can reduce red blood cell (RBC) transfusion...
5.
Junek M, Hu A, Garner S, Rebello R, Legault K, Beattie K, et al.
Rheumatology (Oxford)
. 2021 Jan;
60(9):4229-4237.
PMID: 33404650
Objectives: Imaging modalities have become common in evaluating patients for a possible diagnosis of GCA. This study seeks to contextualize how temporal arterial magnetic resonance angiography (TA-MRA) can be used...
6.
Ing E, Miller N, Nguyen A, Su W, Bursztyn L, Poole M, et al.
Clin Ophthalmol
. 2019 Mar;
13:421-430.
PMID: 30863010
Purpose: To develop and validate neural network (NN) vs logistic regression (LR) diagnostic prediction models in patients with suspected giant cell arteritis (GCA). Design: Multicenter retrospective chart review. Methods: An...
7.
Wang H, Chauhan J, Hu A, Pendleton K, Yap J, Sabato P, et al.
Oncotarget
. 2018 Nov;
9(80):35196.
PMID: 30416689
[This corrects the article DOI: 10.18632/oncotarget.1108.].
8.
Tian J, Dang H, Hu A, Xu W, Kaufman D
J Diabetes Res
. 2017 Oct;
2017:6403539.
PMID: 29018828
The activation of -cell's A- and B-type gamma-aminobutyric acid receptors (GABA-Rs and GABA-Rs) can promote their survival and replication, and the activation of -cell GABA-Rs promotes their conversion into -cells....
9.
Hu A, Vender R
J Cutan Med Surg
. 2017 Aug;
22(1):31-37.
PMID: 28793799
Background: Canadian dermatology curriculum was reviewed in 1983, 1987, 1996, and 2008. All these surveys highlighted the disproportionately low level of dermatology teaching in relation to the significant amount of...
10.
Wang H, Teriete P, Hu A, Raveendra-Panickar D, Pendelton K, Lazo J, et al.
Oncotarget
. 2015 Oct;
6(32):32380-95.
PMID: 26474287
Many oncogenic signals originate from abnormal protein-protein interactions that are potential targets for small molecule inhibitors. However, the therapeutic disruption of these interactions has proved elusive. We report here that...